Barclays Maintains Overweight on CBRE Group, Lowers Price Target to $174

Benzinga Newsdesk www.benzinga.com Negative 84.4%

Neg 84.4% Neu 0% Pos 0%

Barclays analyst Brendan Lynch maintains CBRE Group (NYSE:CBRE) with a Overweight and lowers the price target from $192 to $174.